Tetyana Denyssevych

Treatment of HER-2/<b> <i>neu</i> </b> Overexpressing Breast Cancer Xenograft Models with Trastuzumab (Herceptin) and Gefitinib (ZD1839): Drug Combination Effects on Tumor Growth, HER-2/<b> <i>neu</i> </b> and Epidermal Growth Factor Receptor Expression, and Viable Hypoxic Cell Fraction

Corinna Warburton, Wieslawa H. Dragowska, Karen A. Gelmon et al. · Clinical Cancer Research · 2004 · 81 citations

Medicine, Oncology, Pharmacology +17

Drug interaction studies between paclitaxel (Taxol) and OC144-093 — A new modulator of MDR in cancer chemotherapy

Emma S. Tomlinson Guns, Tetyana Denyssevych, Ross Dixon et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2002 · 33 citations

Medicine, Oncology, Pharmacology +15

Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1

Tetyana Denyssevych, V.S. Lestou, S Knesevich et al. · Leukemia · 2002 · 10 citations

Medicine, Cell Biology, Oncology +10